[HPV vaccine in the last trial phase. Is cervix carcinoma soon to be eradicated?].
Grubert
T A
TA
Frauenklinik, Klinikum Innenstadt, LMU München. thomas.grubert@fk-i.med.uni-muenchen.de
D000293:Adolescent; D000328:Adult; D017326:Clinical Trials, Phase III as Topic; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D027383:Papillomaviridae / Q000276:immunology*; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000517:prevention & control*; D014614:Vaccines, Synthetic / Q000008:administration & dosage* / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000276:immunology; D002578:Uterine Cervical Dysplasia / Q000276:immunology / Q000517:prevention & control*
D053918:Papillomavirus Vaccines; D014614:Vaccines, Synthetic; D014765:Viral Vaccines